Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |